Systemic lupus erythematosus and human endogenous retroviruses

Modern Rheumatology

Volumn 13, Issue 2, 2003, Pages 107-113

  Sekigawa, Iwao ^a   Ogasawa, Hitoshi ^b   Naito, Toshio ^b   Kaneko, Hiroshi ^b   Hishikawa, Takashi ^b   Hashimoto, Hiroshi ^b  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA methylation; Human endogenous retrovirus (HERV); Interleukin (IL) 16; Systemic lupus erythematosus (SLE)

Indexed keywords

AUTOIMMUNITY; HUMAN; HUMAN GENOME; IMMUNOPATHOGENESIS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RETROVIRUS; REVIEW; RNA VIRUS; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS PATHOGENESIS; VIRUS TRANSCRIPTION;

EID: 0041671142     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.3109/s10165-002-0208-3     Document Type: Review

References (56)

1. Tanaka A, Sugawara A, Sawai K, Kuwahara T. Human parvovirus B19 infection resembling systemic lupus erythematosus. Intern Med 1998;37:708-10.
2. James JA, Neas BR, Moser KL, Holl T, Bruner GR, Sestak AL, et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001;44:1122-6.
3. Sekigawa I, Nawata N, Seta N, Yamada M, Iida N, Hashimoto H. Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2002;20:559-64.
4. Herrmann M, Hagenhofer M, Kalden JR. Retroviruses and systemic lupus erythematosus. Immunol Rev 1996;152:145-56.
5. Nakagawa K, Harrison LC. The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev 1996;152:193-236.
6. Löwer R. The pathogenic potential of endogenous retroviruses: facts and fantasies. Trends Microbiol 1999;7:350-6.
7. Denman AM. Systemic lupus erythematosus - is a viral aetiology a credible hypothesis? J Infect 2000;40:229-33.
8. Sekigawa I, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H. Retroviruses and autoimmunity. Intern Med 2001;40:80-6.
9. Perl A. Endogenous retroviruses in pathogenesis of autoimmunity. J Rheumatol 2001;28:461-4.
10. Poris JL. Perspectives on the role of endogenous human retroviruses in autoimmune diseases. Virology 2002;296:1-5.
11. Urnovitz HB, Murphy WH. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev 1996;9:72-99.
12. Löwer R, Löwer J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequence. Proc Natl Acad Sci USA 1996;93:5177-84.
13. Tristem M. Identification and characterization of novel human endogenous retrovirus families by phylogenic screening of the human genome mapping project database. J Virol 2000;74:3715-30.
14. International SNP Map Working Group. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature (Lond) 2001;409:928-33.
15. International Human Genome Mapping Consortium. A physical map of the human genome. Nature (Lond) 2001;409:934-41.
16. Fanning T, Alves G. A family of repetitive DNA sequences in old world primates. Gene (Amst) 1997;199:279-82.
17. Repaske R, Steele PE, O'Neill RR, Rabson AB, Martin MA. Nucleotide sequence of a full-length human endogenous retroviral segment. J Virol 1985;54:764-72.
18. Taruscio D, Manuelidis L, Integration site preferences of endogenous retroviruses. Chromosoma (Berl) 1991;101:141-56.
19. Taruscio D, Mantovani A. Eleven chromosomal integration sites of a human endogenous retrovirus (HERV 4-1) map close to known loci of thirteen hereditary malformation syndromes. Teratology 1996;54:108-10.
20. Kitamura M, Maruyama N, Shirasawa T, Nagasawa R, Watanabe K, Tateno M, et al. Expression of an endogenous retroviral gene product in human placenta. Int J Cancer 1994;58:836-40.
21. Query CC, Keene JD. A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 1987;51:211-20.
22. Talal N, Garry RF, Schur PH, Alexander S, Dauphinee MJ, Livas IH, et al. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 1990;85:1866-71.
23. Koshino K, Tokano Y, Hishikawa T, Sekigawa I, Takasaki Y, Hashimoto H. Detection of autoantibodies to HIV-1 gp41 and HLA class II antigen-derived peptides in SLE patients. Scand J Rheumatol 1995;24:288-92.
24. Rose NR, Mackay IR. Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci 2000;57:542-51.
25. Sekigawa I, Groopman JE, Allan JD, Ikeuchi K, Biberfield G, Takatsuki K, et al. Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Clin Immunol Immunopathol 1991;58:145-53.
26. Nauclér CS, Larsson S, Möller E. A novel mechanism for virus-induced autoimmunity in humans. Immunol Rev 1996;152:175-92.
27. + T cell anergy. Clin Exp Immunol 1997;109:41-6.
28. Haraguchi S, Good RA, Cianciolo GJ, Engelman RW, Day NK. Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections. J Leukoc Biol 1997;61:654-66.
29. Yoshiki T, Mellors RC, Strand M, August JT. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 1974;140:1011-27.
30. Shirai T, Ohta K, Kohno A, Furukawa F, Yoshida H, Maruyama N, et al. Naturally occurring antibody response to DNA is associated with the response to retroviral gp70 in autoimmune New Zealand mice. Arthritis Rheum 1986;29:242-50.
31. Wu J, Zhou T, He J, Mountz JD. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993;178:461-8.
32. Brookes SM, Pandolfino YA, Mitchell TJ, Venables PJ, Shattles WG, Clark DA, et al. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 1992;31:735-42.
33. Herrmann M, Kalden JR. PCR and reverse dot hybridization for the detection of endogenous retroviral transcripts. J Virol Methods 1994;46:333-48.
34. Tamura N, Sekigawa I, Hashimoto H, Yamamoto N, Kira S. Syncytial cell formation in vivo by type C retroviral particles in the systemic lupus erythematosus (SLE) lung. Clin Exp Immunol 1997;107:474-9.
35. Sekigawa I, Kaneko H, Hishikawa T, Hashimoto H, Hirose S, Kaneko Y, et al. HIV infection and SLE: their pathogenic relationship. Clin Exp Rheumatol 1998;16:176-80.
36. Sekigawa I, Okada M, Ogasawara H, Naito T, Kaneko H, Hishikawa T, et al. Lessons from similarities between SLE and HIV infection. J Infect 2002;44:67-72.
37. Ogasawara H, Hishikawa T, Sekigawa I, Hashimoto H, Yamamoto N, Maruyama M. Sequence analysis of human endogenous retrovirus clone 4-1 in systemic lupus erythematosus. Autoimmunity 2001;33:15-21.
38. Ogasawara H, Naito T, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H. Quantitative analyses of messenger RNA of human endogenous retrovirus in SLE patients. J Rheumatol 2001;28:533-38.
39. Ogasawara H, Okada M, Kaneko H, Hishikawa T, Sekigawa I, Iida N, et al. Quantitative comparison of human endogenous retrovirus mRNA between SLE and rheumatoid arthritis. Lupus 2001;10: 517-18.
40. Hishikawa T, Kaneko H, Shirasawa T, Matsuura Y, Sekigawa I, Takasaki Y, et al. Detection of antibodies to recombinant gag protein derived from human endogenous retrovirus like sequence, clone 4-1, in autoimmune diseases. Viral Immunol 1997;10:137-47.
41. Karpas A, Lowdell M, Jacobson SK, Hill F. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK506. Proc Natl Acad Sci USA 1992;89:8351-5.
42. Lee S, Kaneko H, Sekigawa I, Tokano Y, Takasaki Y, Hashimoto H. Circulating interleukin-16 in systemic lupus erythematosus. Br J Rheumatol 1998;37:1334-7.
43. Lard LR, Roep BO, Verburgh CA, Zwinderman AH, Huizinga TWJ. Elevated IL-16 levels in patients with systemic lupus erythematosus are associated with disease severity but not with genetic susceptibility to lupus. Lupus 2002;11:181-5.
44. Center DM, Kornfeld H, Cruikshank WW. Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996;17:476-81.
45. Sekigawa I, Matsushita M, Lee S, Maeda N, Ogasawara H, Kaneko H, et al. A possible pathogenic role of CD8+ T cells and their derived cytokine, IL-46, in SLE. Autoimmunity 2001;33:37-44.
46. Matsushita M, Hayashi T, Ando S, Sekigawa I, Iida N, Hashimoto H, et al. Changes of CD4+/CD8+ T cell ratio and IL-16 levels on treatment in SLE patients. Clin Rheumatol 2000;19:270-4.
47. Linker-Israeli M, Quismorio FP Jr, Horwitz DA. Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus. J Rheumatol 1988;15:1216-22.
48. Maeda N, Sekigawa I, Iida N, Matsumoto M, Hashimoto H, Hirose S. Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus. Scand J Rheumatol 1997;26:37-42.
49. Rammensee HG, Friede T, Stevanoviiv S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995;41:178-228.
50. Horwitz DA, Stohl W, Gray JD. T lymphocytes, natural killer cells, cytokines, and immune regulation. In: Wallace DJ, Hann BH, editors. Dubois lupus erythematosus. 5th ed. Baltimore: Williams & Wilkins; 1997. p. 155-94.
51. Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Takasaki Y, Hashimoto H, et al. Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen: with reference to the pathogenesis of systemic lupus erythematosus. Rheumatology 1999;38:1163-4.
52. Okada M, Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, et al. Role of DNA methylation in the transcription of human endogenous retrovirus in the pathogenesis of systemic lupus erythematosus. J Rheumatol 2002;29:1678-82.
53. Cedar H. DNA methylation and gene activation. Cell 1988;53:3-4.
54. Richardson B, Yung R. Role of DNA methylation in the regulation of cell function. J Lab Clin Med 1999;134:333-40.
55. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000;9:2395-402.
56. Goff PL, Saraux A. Drug-induced lupus. Rev Rheum 1999; 66:40-5.